Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (2206)	12/22/2000 6:58:38 AM
From: Micawber	Read Replies (1) of 4974

Friday December 22, 6:42 am Eastern Time ImClone withdraws 6-million share stock offering NEW YORK, Dec 22 (Reuters) - Biopharmaceutical company ImClone Systems Inc. (NasdaqNM:IMCL - news) said on Friday it withdrew a regulatory filing to sell up to six million shares of its common stock. ImClone, which said it filed the registration statement with the Securities and Exchange Commission in November, did not disclose why it was withdrawing the offer. The company's shares closed at $31-13/16 in Thursday trading on the Nasdaq, below their 52-week high of $85-15/16 and above a yearly low of $17.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next